Covered recipient · General Payments record
KATHLEEN M TONKIN
Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology
General Payments · PY2021–2024
$3,117.19
- Reported across 169 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $848.20 | 50 |
| Education | $186.84 | 2 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Janssen Biotech, Inc. | $170.82 | 6 |
| ABBVIE INC. | $158.56 | 8 |
| Lilly USA, LLC | $112.78 | 2 |
| Acerta Pharma LLC | $58.88 | 3 |
| E.R. Squibb & Sons, L.L.C. | $35.76 | 2 |
| Merck Sharp & Dohme Corporation | $32.73 | 2 |
| Daiichi Sankyo Inc. | $32.29 | 2 |
| Stemline Therapeutics Inc. | $32.21 | 2 |
| Alexion Pharmaceuticals, Inc. | $30.07 | 2 |
| Regeneron Healthcare Solutions, Inc. | $29.69 | 2 |
| Gilead Sciences, Inc. | $29.01 | 2 |
| PFIZER INC. | $27.69 | 2 |
| BeiGene USA, Inc. | $23.92 | 1 |
| Genmab U.S., Inc. | $22.09 | 1 |
| Blueprint Medicines Corporation | $20.86 | 1 |
| SOBI, INC | $18.48 | 1 |
| PharmaEssentia USA Corporation | $17.23 | 1 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $17.20 | 1 |
| Novocure Inc. | $17.01 | 1 |
| Exelixis Inc. | $16.73 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $15.97 | 1 |
| Karyopharm Therapeutics Inc. | $15.51 | 1 |
| JAZZ PHARMACEUTICALS INC. | $15.13 | 1 |
| GENZYME CORPORATION | $14.63 | 1 |
| BOSTON SCIENTIFIC CORPORATION | $14.38 | 1 |
| TAIHO ONCOLOGY, INC. | $14.38 | 1 |
| PUMA BIOTECHNOLOGY, INC. | $13.92 | 1 |
| ARRAY BIOPHARMA INC | $13.76 | 1 |
| Astellas Pharma US Inc | $13.35 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (52)
Sorted by paying entity, then date · as published by CMS
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.